Grand Keynote

Joydeep Ganguly is Senior Vice President, Corporate Operations at Gilead Sciences. In his current role, he is accountable for several strategic functions, including: corporate engineering and operations; infrastructure and capital planning; sustainability; risk management and resilience; global procurement; and the program management office. Joydeep also oversees Gilead's corporate real estate portfolio, which comprises more than 8 million square feet of research and development, commercial and administrative space. Prior to Gilead, Joydeep spent 10 years at Biogen, in roles of increasing responsibility in the areas of technical operations, manufacturing and supply chain. A transformational thought leader in the operations space, Joydeep has published extensively about operations transformation, bioprocess optimization and supply chain evolution. The International Society of Pharmaceutical Engineering (ISPE) recognized Joydeep with the Roger Sherwood Journal Article of the Year for his publication about the application of innovative process analytics within operations, an area in which he remains active and holds multiple patents. Joydeep was recently also recognized as a Top 50 Diverse Leader in California, and awarded the Leadership Award by the National Diversity Council. A past board member of the North Carolina Biosciences Organization (NCBIO) and the North Carolina Museum of Life and Sciences, he currently serves on the Board of Directors for the Bay Area Council, Biocom, Science from Scientists and the Gilead Foundation. Joydeep earned a Master of Science in Electrical Engineering from the University of Notre Dame, a Master of Business Administration from North Carolina State University and a Masters degree in Healthcare management from Cornell University.

Mohan Giridharadas is the Founder & CEO of LeanTaaS, a 400-person healthcare analytics company headquartered in Silicon Valley with offices in Charlotte, NC and Newton, MA. LeanTaaS embeds patented optimization algorithms based on lean principles, sophisticated data science, and simulation methodologies into its flagship iQueue suite of products. iQueue enables health systems to increase patient access and lower cost by unlocking capacity in scarce assets. The current suite of products includes iQueue for Infusion Centers, iQueue for Operating Rooms, and iQueue for Inpatient Flow. One or more of the iQueue products have been deployed at over 625 hospitals and 175 leading health systems across the country. These include Academic Medical Centers like Duke, Emory, Penn Medicine, UPMC, Stanford Health Care, UCSF, University of Utah, UCHealth in Colorado, Rush University Medical Center and many more. They also include iconic, mission-focused institutions dedicated to curing cancer such as Memorial Sloan Kettering Cancer Center and the University of Texas MD Anderson Cancer Center. Finally, they include numerous standalone and networked hospitals such as Multicare, Providence, Banner Health, CommonSpirit and many others. Mohan is the co-author of the book Better Healthcare Through Math. Prior to starting LeanTaaS in 2010, Mohan was a senior partner at McKinsey & Company. During his 18-year tenure at McKinsey, Mohan led the Lean Manufacturing and Lean Service Operations Practice in North America and for the Asia-Pacific Region while based out of Sydney and Singapore. He was also on the committee responsible for evaluating candidates for election to the worldwide partnership of the Firm. Mohan holds an MBA from Stanford Graduate School of Business, an MS in Computer Science from Georgia Institute of Technology, and a B.Tech from IIT Bombay. He has been a member of the Continuing Studies faculty at Stanford University and the MBA faculty at the Haas School of Business at the University of California Berkeley where he taught classes on the application of lean principles to achieve excellence in service operations. Mohan has been named by Becker's Hospital Review as one of the Top Entrepreneurs Innovating in Healthcare and one of the Great Healthcare Leaders to know in 2023.